Manufacturers Life Insurance Company, The Outlook Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.02 - $1.89 $19,406 - $35,959	19,026 Added 41.06%	65,368 $113,000
Q2 2022 Aug 15, 2022	SELL	$0.91 - $2.01 $42,171 - $93,147	-46,342 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$1.22 - $2.03 $56,537 - $94,074	46,342 New	46,342 $82,000
Q1 2022 May 20, 2022	BUY	$1.22 - $2.03 $56,537 - $94,074	46,342 New	46,342 $82,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.19B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.